Clicky

Sunday, November 15, 2026

Breaking News

Latest SEC filings as they come in

Kadre Manuel Acquires Restricted Stock Units in Republic Services

Kadre Manuel acquires 117.47 restricted stock units in Republic Services, signaling confidence in the company's future.

Michael Larson acquires restricted stock units from Republic Services

Michael Larson acquires 115.64 restricted stock units from Republic Services, signaling ongoing commitment and reflecting trends in executive compensation.

Bowie James Ulrich acquires 10,000 stock options at Exozyme

Bowie James Ulrich reports acquiring 10,000 stock options in Exozyme, reflecting confidence in the company's future and potentially influencing the biological products sector.

Rubin Shmuel Reports Equity Compensation Change in SEC Filing

Rubin Shmuel's SEC filing details a new equity compensation program aimed at aligning executive pay with long-term growth and shareholder value.

EXOZYMES INC. Reports Stock Option Transaction by Director

EXOZYMES INC. discloses a stock option transaction by director Christopher Marlett, indicating ongoing activity in the biological products sector.

Craig Ian M. Acquires Restricted Stock Units at Republic Services

Craig Ian M. acquires restricted stock units, reflecting ongoing compensation strategies at Republic Services. Industry implications may follow.

Flower Johanna Amends Filing for Restricted Stock Units

Flower Johanna corrects a filing related to restricted stock units, emphasizing the importance of accurate financial disclosures in the software services industry.

BillionToOne's Thomas Lynch Acquires 2,000 Shares

BillionToOne, Inc. reports stock acquisition by officer Thomas Lynch, signaling confidence in the company's growth within the medical laboratories sector.

Harris Ronan sells shares to cover tax obligations

Harris Ronan, CCO of Snap Inc, sold shares to cover tax obligations related to restricted stock units, reflecting ongoing trends in executive stock management.

Vogelstein R Jacob acquires nearly 2 million shares of IAM

Vogelstein R Jacob reports acquisition of nearly 2 million shares of Iambic Therapeutics, signaling potential confidence in the company.

Jeffrey McCall acquires 1,791 shares of Tejon Ranch Co.

Jeffrey McCall has acquired 1,791 shares of Tejon Ranch Co., increasing his ownership stake to 13,089 shares, as reported in a recent SEC filing.

EXOZYMES INC. Reports Stock Option Grant for Director

EXOZYMES INC. files a report detailing a stock option grant for director Anthony DiGiandomenico, emphasizing ongoing personnel incentives.

Oracle CEO Sicilia acquires 446,197 restricted stock units

Michael D. Sicilia, CEO of Oracle Corp, acquires 446,197 restricted stock units, reflecting a strategic move in executive compensation.

Iambic Therapeutics Chairperson Reports Major Stock Transactions

Iambic Therapeutics' Chairperson William H. Rastetter reports significant stock transactions, indicating strategic moves within the company.

Smith Maria Reports Restricted Stock Unit Transaction at Oracle

Smith Maria, Oracle's EVP, disclosed a transaction of 66,930 restricted stock units, emphasizing executive compensation trends in the tech industry.

Thomas W. Handley acquires restricted stock units from Republic

Thomas W. Handley reports acquisition of restricted stock units from Republic Services, reflecting executive compensation trends in the refuse systems industry.

EXOZYMES INC. Grants Stock Options to Director Lon E. Bell

EXOZYMES INC. has granted stock options to director Lon E. Bell, reflecting a strategy to align leadership interests with shareholder value.

Rayo Edgardo Javier Acquires 25,000 Stock Options in ExoZymes

Rayo Edgardo Javier's SEC filing shows he acquired 25,000 stock options in ExoZymes Inc., increasing his total shares to 77,909.

LINEBARGER NORMAN THOMAS Reports Restricted Stock Units Transaction

LINEBARGER NORMAN THOMAS disclosed a transaction involving restricted stock units, reflecting ongoing trends in executive compensation at Republic Services.

Lalonde James Joseph Reports 10,000 Share Stock Option Grant

Lalonde James Joseph has reported a stock option grant of 10,000 shares in Exozyme Inc., reflecting the company's strategy to incentivize key personnel.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →